Click here to get full coverage on Johnson & Johnson Stock (JNJ) Today: FDA Fast‑Track Voucher Lifts Oncology Narrative as Talc Verdict Renews Legal Overhang - ts2.tech

Johnson & Johnson Stock (JNJ) Today: FDA Fast‑Track Voucher Lifts Oncology Narrative as Talc Verdict Renews Legal Overhang  ts2.tech

Johnson & Johnson Stock (JNJ) Today: FDA Fast‑Track Voucher Lifts Oncology Narrative as Talc Verdict Renews Legal Overhang - ts2.tech

Click here to get full coverage on J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod - Fierce Pharma

J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod  Fierce Pharma

J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod - Fierce Pharma

Click here to get full coverage on Jury orders Johnson & Johnson to pay $40 million to two women in latest talc trial - Reuters

Jury orders Johnson & Johnson to pay $40 million to two women in latest talc trial  ReutersJury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders  ABC NewsJ&J loses latest talc case; ordered to pay $40M to two women  Seeking Alpha

Jury orders Johnson & Johnson to pay $40 million to two women in latest talc trial - Reuters

Click here to get full coverage on Balanced Risk-Reward Profile for Johnson & Johnson Amid Limited Stock Re-Rating Potential - TipRanks

Balanced Risk-Reward Profile for Johnson & Johnson Amid Limited Stock Re-Rating Potential  TipRanks

Balanced Risk-Reward Profile for Johnson & Johnson Amid Limited Stock Re-Rating Potential - TipRanks

Click here to get full coverage on Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impact - Benzinga

Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impact  Benzinga

Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impact - Benzinga

Click here to get full coverage on FDA ‘proactively’ awards J&J a national priority review voucher for multiple myeloma drug combo - Fierce Pharma

FDA ‘proactively’ awards J&J a national priority review voucher for multiple myeloma drug combo  Fierce Pharma

FDA ‘proactively’ awards J&J a national priority review voucher for multiple myeloma drug combo - Fierce Pharma

Click here to get full coverage on J&J buys into Halda's cell death tech with $3B acquisition, beefing up prostate cancer pipeline - Fierce Biotech

J&J buys into Halda's cell death tech with $3B acquisition, beefing up prostate cancer pipeline  Fierce Biotech

J&J buys into Halda's cell death tech with $3B acquisition, beefing up prostate cancer pipeline - Fierce Biotech

Click here to get full coverage on Leading where medicine is going - Johnson & Johnson

Leading where medicine is going  Johnson & Johnson

Leading where medicine is going - Johnson & Johnson

Click here to get full coverage on California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson - Action News Now

California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson  Action News Now

California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson - Action News Now

Click here to get full coverage on J&J’s talc trouble continues: Johnson & Johnson ordered to pay $40 million in baby powder cancer case - Times of India

J&J’s talc trouble continues: Johnson & Johnson ordered to pay $40 million in baby powder cancer case  Times of India

J&J’s talc trouble continues: Johnson & Johnson ordered to pay $40 million in baby powder cancer case - Times of India

Click here to get full coverage on Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results - Yahoo Finance

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results  Yahoo Finance

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results - Yahoo Finance

Click here to get full coverage on Johnson & Johnson’s JNJ-5322 shows improved efficacy in MM - BioWorld MedTech

Johnson & Johnson’s JNJ-5322 shows improved efficacy in MM  BioWorld MedTech

Johnson & Johnson’s JNJ-5322 shows improved efficacy in MM - BioWorld MedTech

Click here to get full coverage on These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same? - The Motley Fool

These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same?  The Motley Fool

These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same? - The Motley Fool

Click here to get full coverage on Johnson & Johnson Stock (JNJ) Opinions on Recent FDA Approval and Legal Challenges - Quiver Quantitative

Johnson & Johnson Stock (JNJ) Opinions on Recent FDA Approval and Legal Challenges  Quiver Quantitative

Johnson & Johnson Stock (JNJ) Opinions on Recent FDA Approval and Legal Challenges - Quiver Quantitative

Click here to get full coverage on Notable Monday Option Activity: BBY, JNJ, AMC - Nasdaq

Notable Monday Option Activity: BBY, JNJ, AMC  Nasdaq

Notable Monday Option Activity: BBY, JNJ, AMC - Nasdaq

Click here to get full coverage on Johnson & Johnson (NYSE:JNJ) Trading Up 1.3% Following Analyst Upgrade - MarketBeat

Johnson & Johnson (NYSE:JNJ) Trading Up 1.3% Following Analyst Upgrade  MarketBeat

Johnson & Johnson (NYSE:JNJ) Trading Up 1.3% Following Analyst Upgrade - MarketBeat

Click here to get full coverage on J&J Tecvayli/Darzalex combo granted FDA national priority voucher (JNJ:NYSE) - Seeking Alpha

J&J Tecvayli/Darzalex combo granted FDA national priority voucher (JNJ:NYSE)  Seeking Alpha

J&J Tecvayli/Darzalex combo granted FDA national priority voucher (JNJ:NYSE) - Seeking Alpha

Click here to get full coverage on US FDA grants priority voucher to J&J's blood cancer treatment - Reuters

US FDA grants priority voucher to J&J's blood cancer treatment  Reuters

US FDA grants priority voucher to J&J's blood cancer treatment - Reuters

Click here to get full coverage on Johnson & Johnson MedTech to shift to business unit-led structure in 2026 - MassDevice

Johnson & Johnson MedTech to shift to business unit-led structure in 2026  MassDevice

Johnson & Johnson MedTech to shift to business unit-led structure in 2026 - MassDevice

Click here to get full coverage on Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance

Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True?  Yahoo Finance

Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance

Click here to get full coverage on Johnson & Johnson Stock After Hours (Dec. 15, 2025): JNJ Rises on FDA Priority Voucher — What to Know Before Tuesday’s Open - ts2.tech

Johnson & Johnson Stock After Hours (Dec. 15, 2025): JNJ Rises on FDA Priority Voucher — What to Know Before Tuesday’s Open  ts2.tech

Johnson & Johnson Stock After Hours (Dec. 15, 2025): JNJ Rises on FDA Priority Voucher — What to Know Before Tuesday’s Open - ts2.tech

Click here to get full coverage on New Analyst Forecast: $JNJ Given $220 Price Target - Quiver Quantitative

New Analyst Forecast: $JNJ Given $220 Price Target  Quiver Quantitative

New Analyst Forecast: $JNJ Given $220 Price Target - Quiver Quantitative

Click here to get full coverage on ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma - Fierce Pharma

ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma  Fierce Pharma

ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma - Fierce Pharma

Click here to get full coverage on Bank of America Issues Positive Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price - MarketBeat

Bank of America Issues Positive Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price  MarketBeat

Bank of America Issues Positive Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price - MarketBeat

Click here to get full coverage on Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates - Yahoo Finance

Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates  Yahoo Finance

Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates - Yahoo Finance

Click here to get full coverage on Johnson & Johnson (JNJ) Stock News Today, Forecasts and Analyst Targets (Dec. 12, 2025) - ts2.tech

Johnson & Johnson (JNJ) Stock News Today, Forecasts and Analyst Targets (Dec. 12, 2025)  ts2.tech

Johnson & Johnson (JNJ) Stock News Today, Forecasts and Analyst Targets (Dec. 12, 2025) - ts2.tech

Click here to get full coverage on Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider  Yahoo Finance

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Click here to get full coverage on Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy - Yahoo Finance

Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy  Yahoo Finance

Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy - Yahoo Finance

Click here to get full coverage on Johnson & Johnson Ordered to Pay $40 Million in Key Talc Ovarian Cancer Trial - Drugwatch.com

Johnson & Johnson Ordered to Pay $40 Million in Key Talc Ovarian Cancer Trial  Drugwatch.com

Johnson & Johnson Ordered to Pay $40 Million in Key Talc Ovarian Cancer Trial - Drugwatch.com

Click here to get full coverage on Jury orders Johnson & Johnson to pay $40M to two women in latest talc trial - The Journal Record

Jury orders Johnson & Johnson to pay $40M to two women in latest talc trial  The Journal Record

Jury orders Johnson & Johnson to pay $40M to two women in latest talc trial - The Journal Record

Click here to get full coverage on Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum - Yahoo Finance

Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum  Yahoo Finance

Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on Johnson & Johnson - Britannica

Johnson & Johnson - Britannica

Click here to get full coverage on Johnson & Johnson: Reliable Cash Flows, Moderate Expectations - Seeking Alpha

Johnson & Johnson: Reliable Cash Flows, Moderate Expectations  Seeking Alpha

Johnson & Johnson: Reliable Cash Flows, Moderate Expectations - Seeking Alpha

Click here to get full coverage on Orion Porfolio Solutions LLC Grows Position in Johnson & Johnson $JNJ - MarketBeat

Orion Porfolio Solutions LLC Grows Position in Johnson & Johnson $JNJ  MarketBeat

Orion Porfolio Solutions LLC Grows Position in Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Stonebridge Wealth Management LLC Invests $756,000 in Johnson & Johnson $JNJ - MarketBeat

Stonebridge Wealth Management LLC Invests $756,000 in Johnson & Johnson $JNJ  MarketBeat

Stonebridge Wealth Management LLC Invests $756,000 in Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on MASTERINVEST Kapitalanlage GmbH Takes $2.35 Million Position in Johnson & Johnson $JNJ - MarketBeat

MASTERINVEST Kapitalanlage GmbH Takes $2.35 Million Position in Johnson & Johnson $JNJ  MarketBeat

MASTERINVEST Kapitalanlage GmbH Takes $2.35 Million Position in Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Kentucky Retirement Systems Sells 10,134 Shares of Johnson & Johnson $JNJ - MarketBeat

Kentucky Retirement Systems Sells 10,134 Shares of Johnson & Johnson $JNJ  MarketBeat

Kentucky Retirement Systems Sells 10,134 Shares of Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Osaic Holdings Inc. Acquires 80,518 Shares of Johnson & Johnson $JNJ - MarketBeat

Osaic Holdings Inc. Acquires 80,518 Shares of Johnson & Johnson $JNJ  MarketBeat

Osaic Holdings Inc. Acquires 80,518 Shares of Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Rep. Julie Johnson Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat

Rep. Julie Johnson Sells Off Shares of Johnson & Johnson (NYSE:JNJ)  MarketBeat

Rep. Julie Johnson Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat

Click here to get full coverage on Johnson & Johnson, Oscar nominee Naomi Watts cast an eye to the future - Medical Marketing and Media

Johnson & Johnson, Oscar nominee Naomi Watts cast an eye to the future  Medical Marketing and Media

Johnson & Johnson, Oscar nominee Naomi Watts cast an eye to the future - Medical Marketing and Media

Click here to get full coverage on Johnson & Johnson $JNJ Shares Bought by Cim Investment Management Inc. - MarketBeat

Johnson & Johnson $JNJ Shares Bought by Cim Investment Management Inc.  MarketBeat

Johnson & Johnson $JNJ Shares Bought by Cim Investment Management Inc. - MarketBeat

Click here to get full coverage on JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now? - Yahoo Finance

JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?  Yahoo Finance

JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now? - Yahoo Finance

Click here to get full coverage on Thrivent Financial for Lutherans Has $230.67 Million Stock Position in Johnson & Johnson $JNJ - MarketBeat

Thrivent Financial for Lutherans Has $230.67 Million Stock Position in Johnson & Johnson $JNJ  MarketBeat

Thrivent Financial for Lutherans Has $230.67 Million Stock Position in Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Johnson & Johnson Delivers Steady Growth But Limited Surprises - Finimize

Johnson & Johnson Delivers Steady Growth But Limited Surprises  Finimize

Johnson & Johnson Delivers Steady Growth But Limited Surprises - Finimize

Click here to get full coverage on LA jury finds J&J liable for women's cancer in bellwether - Daily Journal

LA jury finds J&J liable for women's cancer in bellwether  Daily Journal

LA jury finds J&J liable for women's cancer in bellwether - Daily Journal

Click here to get full coverage on Social impact - Johnson & Johnson

Social impact - Johnson & Johnson

Click here to get full coverage on The Bull Case For Johnson & Johnson (JNJ) Could Change Following New Multiple Myeloma Breakthrough Data - Yahoo Finance

The Bull Case For Johnson & Johnson (JNJ) Could Change Following New Multiple Myeloma Breakthrough Data  Yahoo Finance

The Bull Case For Johnson & Johnson (JNJ) Could Change Following New Multiple Myeloma Breakthrough Data - Yahoo Finance

Click here to get full coverage on J&J leads $60 million Series A for newly-launched Link Cell - The Pharma Letter

J&J leads $60 million Series A for newly-launched Link Cell  The Pharma Letter

J&J leads $60 million Series A for newly-launched Link Cell - The Pharma Letter

Click here to get full coverage on Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study - Yahoo Finance

Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study  Yahoo Finance

Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study - Yahoo Finance

Click here to get full coverage on J&J’s US orthopedic leader leaves amid DePuy spinout process - MedTech Dive

J&J’s US orthopedic leader leaves amid DePuy spinout process  MedTech Dive

J&J’s US orthopedic leader leaves amid DePuy spinout process - MedTech Dive

Click here to get full coverage on Clarion Wealth Managment Partners LLC Purchases New Holdings in Johnson & Johnson $JNJ - MarketBeat

Clarion Wealth Managment Partners LLC Purchases New Holdings in Johnson & Johnson $JNJ  MarketBeat

Clarion Wealth Managment Partners LLC Purchases New Holdings in Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Johnson & Johnson (NYSE:JNJ) Shares Ease on Sector Sentiment Shift - Kalkine Media

Johnson & Johnson (NYSE:JNJ) Shares Ease on Sector Sentiment Shift  Kalkine Media

Johnson & Johnson (NYSE:JNJ) Shares Ease on Sector Sentiment Shift - Kalkine Media

Click here to get full coverage on How Recent Developments Are Rewriting the Story for Johnson & Johnson - Yahoo Finance

How Recent Developments Are Rewriting the Story for Johnson & Johnson  Yahoo Finance

How Recent Developments Are Rewriting the Story for Johnson & Johnson - Yahoo Finance

Click here to get full coverage on 1 Reason Why Shares of Johnson & Johnson Are Surging This Month - The Motley Fool

1 Reason Why Shares of Johnson & Johnson Are Surging This Month  The Motley Fool

1 Reason Why Shares of Johnson & Johnson Are Surging This Month - The Motley Fool

Click here to get full coverage on Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025) - ts2.tech

Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025)  ts2.tech

Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025) - ts2.tech

Click here to get full coverage on Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA - MassDevice

Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA  MassDevice

Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA - MassDevice

Click here to get full coverage on Policies and reports - Johnson & Johnson

Policies and reports  Johnson & Johnson

Policies and reports - Johnson & Johnson

Click here to get full coverage on 14,888 Shares in Johnson & Johnson $JNJ Acquired by North Dallas Bank & Trust Co. - MarketBeat

14,888 Shares in Johnson & Johnson $JNJ Acquired by North Dallas Bank & Trust Co.  MarketBeat

14,888 Shares in Johnson & Johnson $JNJ Acquired by North Dallas Bank & Trust Co. - MarketBeat

Click here to get full coverage on J&J Impact Ventures - Johnson & Johnson

J&J Impact Ventures - Johnson & Johnson

Click here to get full coverage on Mesothelioma Advocates Cheered by $40 Million Johnson & Johnson Ovarian Cancer Verdict - Mesothelioma.net

Mesothelioma Advocates Cheered by $40 Million Johnson & Johnson Ovarian Cancer Verdict  Mesothelioma.net

Mesothelioma Advocates Cheered by $40 Million Johnson & Johnson Ovarian Cancer Verdict - Mesothelioma.net

Click here to get full coverage on Assessing Johnson & Johnson’s Valuation After a 47% Surge and Strong Cash Flow Outlook - simplywall.st

Assessing Johnson & Johnson’s Valuation After a 47% Surge and Strong Cash Flow Outlook  simplywall.st

Assessing Johnson & Johnson’s Valuation After a 47% Surge and Strong Cash Flow Outlook - simplywall.st

Click here to get full coverage on Top Research Reports for Broadcom, Exxon Mobil & Johnson & Johnson - Yahoo Finance

Top Research Reports for Broadcom, Exxon Mobil & Johnson & Johnson  Yahoo Finance

Top Research Reports for Broadcom, Exxon Mobil & Johnson & Johnson - Yahoo Finance

Click here to get full coverage on The Zacks Analyst Blog Highlights Broadcom, Exxon Mobil, Johnson & Johnson, Investors Title and Friedman Industries - Yahoo Finance

The Zacks Analyst Blog Highlights Broadcom, Exxon Mobil, Johnson & Johnson, Investors Title and Friedman Industries  Yahoo Finance

The Zacks Analyst Blog Highlights Broadcom, Exxon Mobil, Johnson & Johnson, Investors Title and Friedman Industries - Yahoo Finance

Click here to get full coverage on Johnson & Johnson MedTech president of U.S. Orthopaedics is leaving - MassDevice

Johnson & Johnson MedTech president of U.S. Orthopaedics is leaving  MassDevice

Johnson & Johnson MedTech president of U.S. Orthopaedics is leaving - MassDevice

Click here to get full coverage on Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally - Yahoo Finance

Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally  Yahoo Finance

Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally - Yahoo Finance

Click here to get full coverage on Westwood Holdings Group Inc. Cuts Stake in Johnson & Johnson $JNJ - MarketBeat

Westwood Holdings Group Inc. Cuts Stake in Johnson & Johnson $JNJ  MarketBeat

Westwood Holdings Group Inc. Cuts Stake in Johnson & Johnson $JNJ - MarketBeat

Click here to get full coverage on Johnson & Johnson to collaborate with the New York Jets to promote better health in the community - Johnson & Johnson

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community  Johnson & Johnson

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community - Johnson & Johnson

Click here to get full coverage on Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer  Johnson & Johnson

JNJ

Price Chart

Key Statistics

Technicals

About JNJ

Latest News

Johnson & Johnson Stock (JNJ) Today: FDA Fast‑Track Voucher Lifts Oncology Narrative as Talc Verdict Renews Legal Overhang - ts2.tech

J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod - Fierce Pharma

Jury orders Johnson & Johnson to pay $40 million to two women in latest talc trial - Reuters

Advanced Charts

Top Gainers

Top Losers